Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Net of Tax
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Net of Tax of $6.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $6.70M.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $17.00M.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $12.10M, a 51.25% increase year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $13.70M.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for fiscal 2025 was $6.20M.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for fiscal 2024 was -$1.70M, a 114.05% decline from fiscal 2023.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for fiscal 2023 was $12.10M.
- Edwards Lifesciences Corporation other comprehensive income (loss), net of tax for fiscal 2022 was -$97.20M, a 2958.82% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.70M 10-Q · filed 2026-08-04 | $23.70M 10-Q · filed 2026-08-04 | $35.80M derived: sum of 3 quarters · filed 2026-08-04 | $49.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $17.00M 10-Q · filed 2026-05-06 | $29.10M derived: sum of 2 quarters · filed 2026-05-06 | $42.80M derived: sum of 3 quarters · filed 2026-05-06 | $33.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $25.80M derived: sum of 2 quarters · filed 2026-02-25 | $16.20M derived: sum of 3 quarters · filed 2026-08-04 | $6.20M 10-K · filed 2026-02-25 |
| 2025-09-30 | $13.70M 10-Q · filed 2025-11-05 | $4.10M derived: sum of 2 quarters · filed 2026-08-04 | -$5.90M 10-Q · filed 2025-11-05 | $2.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$9.60M 10-Q · filed 2026-08-04 | -$19.60M 10-Q · filed 2026-08-04 | -$11.60M derived: sum of 3 quarters · filed 2026-08-04 | -$43.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$10.00M 10-Q · filed 2026-05-06 | -$2.00M derived: sum of 2 quarters · filed 2026-05-06 | -$34.30M derived: sum of 3 quarters · filed 2026-05-06 | -$21.20M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$24.30M derived: sum of 2 quarters · filed 2026-02-25 | -$11.20M derived: sum of 3 quarters · filed 2026-02-25 | -$1.70M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$32.30M 10-Q · filed 2025-11-05 | -$19.20M derived: sum of 2 quarters · filed 2025-11-05 | -$9.70M 10-Q · filed 2025-11-05 | -$2.40M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $13.10M 10-Q · filed 2025-08-06 | $22.60M 10-Q · filed 2025-08-06 | $29.90M derived: sum of 3 quarters · filed 2026-02-25 | $35.30M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $9.50M 10-Q · filed 2025-05-06 | $16.80M derived: sum of 2 quarters · filed 2026-02-25 | $22.20M derived: sum of 3 quarters · filed 2026-02-25 | $22.10M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.70M derived: sum of 2 quarters · filed 2026-02-25 | $12.60M derived: sum of 3 quarters · filed 2026-02-25 | $12.10M 10-K · filed 2026-02-25 |
| 2023-09-30 | $5.40M 10-Q · filed 2024-11-06 | $5.30M derived: sum of 2 quarters · filed 2024-11-06 | $4.80M 10-Q · filed 2024-11-06 | $5.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$100.00K 10-Q · filed 2024-07-31 | -$600.00K 10-Q · filed 2024-07-31 | $500.00K derived: sum of 3 quarters · filed 2025-02-28 | -$31.10M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$500.00K 10-Q · filed 2024-04-29 | $600.00K derived: sum of 2 quarters · filed 2025-02-28 | -$31.00M derived: sum of 3 quarters · filed 2025-02-28 | -$68.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$30.50M derived: sum of 2 quarters · filed 2025-02-28 | -$68.30M derived: sum of 3 quarters · filed 2025-02-28 | -$97.20M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$31.60M 10-Q · filed 2023-10-27 | -$69.40M derived: sum of 2 quarters · filed 2023-10-27 | -$98.30M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | -$37.80M 10-Q · filed 2023-07-28 | -$66.70M 10-Q · filed 2023-07-28 | ||
| 2021-12-31 | $3.40M 10-K · filed 2024-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |